For citations:
Zastrozhin M.S., Sorokin A.S., Agibalova T.V., Bedina I.A., Grishina E.A., Antonenko A.P., Rozochkin I.N., Galaktionova T.E., Barna I.V., Skryabin V.Yu., Orlova A.V., Aguzarov A.D., Savchenko L.M., Bryun E.A., Sychev D.A. Expirience of implementation of personalized clinical decision support system for dosing of bromdihydrochlorphenylbenzodiazepine in patients with alcohol withdraw syndrome based on the pharmacogenomic markers. Medical Genetics. 2019;18(1):13-24. (In Russ.) https://doi.org/ 10.25557/2073-7998.2019.01.13-24
Email this article 